Immix Biopharma (IMMX) Amortizatization of Intangibles (2021 - 2026)

Immix Biopharma has reported Amortizatization of Intangibles for 4 years, with the latest figure at $39189.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles rose 86.37% year-over-year to $39189.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $136916.0 (up 65.69% YoY) and the FY2025 annual result came in at $118754.0, up 44.04% from the prior year.
• Amortizatization of Intangibles improved to $39189.0 in Q1 2026 per IMMX's latest filing, from $38517.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $39189.0 in Q1 2026 and troughed at $20416.0 in Q2 2024.
• A 3-year average of $26710.0 and a median of $21027.0 in 2025 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles increased 0.9% in 2025, then jumped 86.37% in 2026.
• Over 3 years, Amortizatization of Intangibles stood at $20734.0 in 2024, then surged by 85.77% to $38517.0 in 2025, then advanced by 1.74% to $39189.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $39189.0, $38517.0, and $37869.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.